Home›Compare›FeelGood vs Syra Rx

FeelGood vs Syra Rx: Which Is Better?

Head-to-head comparison of FeelGood and Syra Rx based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

FeelGood scores higher overall in our independent evaluation (61/100 vs 53.5/100), leading on value, experience. Syra Rx comes out ahead on product range. Syra Rx has the lower entry price (from $30/mo vs $75/mo), so the better value depends on which treatment you need.

61

FeelGood is a 2026-launched, OpenLoop-powered GLP-1 brand whose promotional page offers compounded semaglutide from $89/mo and tirzepatide from $149/mo with no membership fee, alongside ED and 'longevity' microdose tirzepatide programs.

Visit FeelGood
54
Syra Rx
Below Average

Syra Rx is a 2026-launched, affiliate-distributed telehealth storefront for compounded GLP-1s, NAD+, sermorelin, tesamorelin and ED treatment, with clinical care outsourced to LocumTele and fulfillment by Rush Pharmacy.

Visit Syra Rx

Score Breakdown

DimensionFeelGoodSyra Rx
Overall Score61/100 ✓53.5/100
Trust & Safety30%50/10050/100
Value25%80/100 ✓56/100
Experience20%65/100 ✓50/100
Product Range15%60/10070/100 ✓
Reputation10%40/10040/100

At a Glance

Founded20262026
HeadquartersSheridan, WY—
Publicly tradedNoNo
Treatment categories43
Treatments listed35
Starting price$75/mo$30/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryFeelGoodSyra Rx
Weight Loss / GLP-1$75–$149
Compounded Semaglutide (injectable)
$199–$399
Compounded GLP-1 (semaglutide/tirzepatide)
Sexual Health—$30–$100
ED Treatment
Longevity & Peptides—$150–$250
Compounded Sermorelin

FeelGood

+Promotional pricing is among the lowest tracked: compounded semaglutide $89/mo and tirzepatide $149/mo, with no membership fee and free shipping
+Clinical care is delivered through OpenLoop's established telehealth provider network
+Native iOS and Android apps plus 24/7 messaging support; HSA/FSA accepted
−Unsubstantiated marketing claims: '100,000+ patients' on a domain registered in February 2026, and a '2.4 years younger' epigenetic-age claim for microdose tirzepatide
−High-pressure sales tactics, including countdown timers, 'price increases soon' banners and 'only 9 spots left this month' prompts
−Prices vary across its own pages ($149 'starting' on the main site vs $89 on the offer page), so the price a patient gets depends on which landing page they arrive through
Read the full FeelGood review →

Syra Rx

+Discloses its provider network (LocumTele) and dispensing pharmacy (Rush Pharmacy) by name in the FAQ
+One of few consumer brands offering tesamorelin alongside sermorelin and NAD+
+States a fast fulfillment window (usually 1–2 business days after approval)
−No prices published anywhere on the site; costs appear only inside third-party intake funnels
−Launched in 2026 with no independent patient reviews and no physical address disclosed
−Terms of service cover only GLP-1 services even though the site markets peptides, NAD+ and ED treatment
Read the full Syra Rx review →

FeelGood vs Syra Rx — FAQ

Is FeelGood better than Syra Rx?

▾

FeelGood scores higher overall in our independent evaluation (61/100 vs 53.5/100), leading on value, experience. Syra Rx comes out ahead on product range. Syra Rx has the lower entry price (from $30/mo vs $75/mo), so the better value depends on which treatment you need.

Is FeelGood or Syra Rx cheaper?

▾

Syra Rx has the lower starting price (from $30/mo vs $75/mo for FeelGood). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do FeelGood and Syra Rx both offer?

▾

Both platforms treat Weight Loss / GLP-1, Sexual Health, Longevity & Peptides. FeelGood covers 4 treatment categories total and Syra Rx covers 3.

Still deciding?